Drug Release and Biocompatibility of a Paclitaxel-Coated Balloon Prepared Using the Electrostatic Spray Method

Abstract

Paclitaxel-coated balloons (PCBs) have become effective treatment options for vascular disease, but long-term drug release and biocompatibility are influenced by the drug patterns. In this work, paclitaxel coatings were prepared via electrostatic spraying, and the effect of D-tartaric acid additives was investigated. Microstructures and surface morphology were studied using Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM), respectively. Drug release was measured in vitro, and biocompatibility was evaluated using the haemolysis rate, platelet adhesion and activation, protein adsorption, cell adhesion, and cell proliferation. Our results showed that a uniform crystalline paclitaxel drug coating was obtained, and that the pattern and release of paclitaxel was influenced by the content of D-tartrate. The contact angle of all coatings was less than that of nylon 12. The drug coatings prepared at a mass ratio of paclitaxel to D-tartaric acid of 2:1 had the highest drug release in a brief period of time. The haemolysis rate of the drug coating was less than 5%. Compared with the control samples, platelet adhesion and activation were significantly reduced, albumin adsorption was increased, and the adsorption of fibrinogen was reduced on the surface of the drug coating. Endothelial cells demonstrated good proliferation after three days of cell culture. Therefore, PCBs with specific patterns have good biocompatibility and drug release, with potential clinical applications in vascular disease.